---
title: "Tencent Holdings  (TCTZF) Receives a Buy from GuoSen"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296190060.md"
description: "GuoSen maintained a Buy rating on Tencent Holdings (TCTZF) with a HK$635.50 price target, while shares closed at HK$446.40. The Street consensus is Strong Buy with an average target of HK$670.61, implying 50.23% upside. CGS International also maintains a Buy rating with a HK$688.50 target."
datetime: "2026-08-18T07:15:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296190060.md)
  - [en](https://longbridge.com/en/news/296190060.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296190060.md)
---

# Tencent Holdings  (TCTZF) Receives a Buy from GuoSen

In a report released yesterday, from GuoSen maintained a Buy rating on Tencent Holdings , with a price target of HK$635.50. The company’s shares closed yesterday at HK$446.40.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tencent Holdings with a HK$670.61 average price target, representing a 50.23% upside. In a report released on August 14, CGS International also maintained a Buy rating on the stock with a HK$688.50 price target.

### Related Stocks

- [TCEHY.US](https://longbridge.com/en/quote/TCEHY.US.md)
- [TCTZF.US](https://longbridge.com/en/quote/TCTZF.US.md)
- [00700.HK](https://longbridge.com/en/quote/00700.HK.md)
- [80700.HK](https://longbridge.com/en/quote/80700.HK.md)
- [HTCD.SG](https://longbridge.com/en/quote/HTCD.SG.md)

## Related News & Research

- [Tencent Details Progress Toward Carbon Neutrality Goals and Outlines AI-Era Priorities | TCEHY Stock News](https://longbridge.com/en/news/296040172.md)
- [Another AI lab is burning through cash as Tencent earnings rise](https://longbridge.com/en/news/295641594.md)
- [LifeSci Capital Reaffirms Their Buy Rating on Spyre Therapeutics (SYRE)](https://longbridge.com/en/news/296003421.md)
- [Barclays Sticks to Its Buy Rating for Prosus (PROSF)](https://longbridge.com/en/news/296063490.md)
- [Roth MKM Keeps Their Buy Rating on Silicon Motion (SIMO)](https://longbridge.com/en/news/296034503.md)